Concussion

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II

Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a…

2 years ago

SyncThink Secures CE Mark for EYE-SYNC Digital Health Platform

Neurotechnology solution gains vital certification needed for EU expansion Palo Alto, CA – (August 10, 2022) – SyncThink, a next generation…

2 years ago

Odyssey Health, Inc. Launches New Corporate Website

Odyssey Health, Inc. Launches New Corporate Website $ODYY - Odyssey Health, Inc. - New Corporate WebsiteLas Vegas, NV, Aug. 04,…

2 years ago

Top Neurology and Chiropractic Clinicians Adopt EYE-SYNC

North Boulder Chiropractic and Restoration Neurology Onboard EYE-SYNC technology to improve patient care with objective data Palo Alto, CA—October 7,…

5 years ago

Premier Lacrosse League Partners with SyncThink, Brings Objective Data to Player Brain Health and Performance

Stamford, CT --May 29, 2019--The Premier Lacrosse League (PLL), America’s first professional field lacrosse league featuring the top 160 male…

5 years ago

NeuroSport™ Onboards EYE-SYNC from SyncThink for Athlete Brain Health Evaluations, Concussion Management and Performance

Palo Alto, CA and Deerfield Beach, FL--May 21, 2019—NeuroSport™, a state-of-the-art concussion assessment, treatment, prevention and ‘return to play’ services…

6 years ago